Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study
Frontiers in Digital Health · 08.06.2026 · 8
DOI: 10.3389/fdgth.2026.1792647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Digital Health, online erschienen am 08.06.2026. Verfasst von Yutaka Sugawara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, International University of Health and Welfare, Narita Hospital, Chiba, Japan. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Electronic patient-reported outcome (ePRO) systems using the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) can improve symptom monitoring, but the feasibility of implementing such systems with a bring-your-own-device (BYOD) approach in routine oncology practice, particularly among older adults, is not well established. We conducted a single-arm prospective observational study in Japan to evaluate weekly BYOD-based ePRO monitoring of adverse events in outpatients receiving chemotherapy. Twenty-eight patients used smartphones to complete weekly PRO-CTCAE/CTCAE-based questionnaires for 12 weeks. Alerts were automatically generated when severity or frequency thresholds were met. Feasibility outcomes were weekly ePRO response rates and the distribution of alert-generating symptoms; HRQoL (EORTC QLQ-C30) was assessed at baseline, week 6, and week 12. The mean age was 66.7 years and most patients had stage IV disease. The weekly ePRO response rate ranged from 75% to 93% in the overall cohort and remained at or above 75% in patients aged ≥70 years. Pain-related items most frequently triggered alerts, followed by numbness and tingling, rash, fatigue, and skin-related disorders. The EORTC QLQ-C30 global health status score increased numerically from 54.8 at baseline to 63.5 at week 6 and 63.4 at week 12, with no marked deterioration observed over 12 weeks. These findings indicate that weekly PRO-CTCAE/CTCAE-based ePRO monitoring using a BYOD approach is feasible in routine outpatient oncology care, including among older adults who use smartphones. This study provides preliminary evidence for BYOD-based ePRO implementation in this underexplored population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Oncology, International University of Health and Welfare, Narita Hospital, Chiba, Japan.
- Patient Engagement Frontier Medical Science, KAKEHASHI Inc., Tokyo, Japan.
- Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan.
- Department of Hematology, Nippon Medical School, Tokyo, Japan.
Zitieren
APA
Sugawara, Y., Kobayashi, M., Mannoji, E., Saika, T., Kado, Y., Yamazaki, M., Takebe, T., & Higuchi, H. (2026). Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1792647
Vancouver
Sugawara Y, Kobayashi M, Mannoji E, Saika T, Kado Y, Yamazaki M, et al. Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1792647
BibTeX
@article{Sugawara2026,
author = {Sugawara, Yutaka and Kobayashi, Momoko and Mannoji, Eri and Saika, Tomoya and Kado, Yuki and Yamazaki, Michiko and Takebe, Tohru and Higuchi, Hajime},
title = {Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study},
journal = {Frontiers in Digital Health},
year = {2026},
volume = {8},
doi = {10.3389/fdgth.2026.1792647}
}
EUVIMED